HIV Infections: all 4,340 studies

Page 3 of 44. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• Microbiota Footprint and Frailty Phenotype in Virologically Suppressed People Living With HIVRecruitingNCT05078957
• Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin LymphomaRecruitingNCT05077527Phase 1
• Getting to Zero Among HHI MSM in the American SouthEnrolling by invitationNCT05075967Not applicable
• Kuwa Free! - Live Free!RecruitingNCT05044962Not applicable
• Effectiveness of a Mobile-based HIV Prevention Intervention Involving Incentive Policy for Doctors in Liangshan, ChinaNot yet recruitingNCT05015062Not applicable
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility StudyRecruitingNCT04949464Not applicable
• A Prospective, Observational Study to Examine the Effects of Ageing on the Clinical Outcomes of People Living With HIV in South KoreaNot yet recruitingNCT04914130
• Antiretroviral Speed Access ProgramRecruitingNCT04897243
• Association Between Human Immunodeficiency Virus (HIV) Infection and Male HypogonadismRecruitingNCT04760574
• Observational Study on Patients With HIV/AIDS(OSPWH)RecruitingNCT04667026
• Sequential Analysis Before and After Treatment Initiation to Unravel the Role of Naturally Occurring Extracellular Vesicles in HIV InfectionRecruitingNCT04653610
• User-friendly HIV Testing and Counseling ServicesRecruitingNCT04585165
• HIV Treatment Adherence Dose Determination TrialRecruitingNCT04577313Not applicable
• HIV Prevention Among At-risk Latinos in the HeartlandEnrolling by invitationNCT04563715Not applicable
• HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open LabelRecruitingNCT04513626Phase 2
• Cardiovascular Responses to Exercise in People Living With HIV/AIDS: Effects of Exercise TrainingRecruitingNCT04512456Not applicable
• mWACh-PrEP: A SMS-based Support Intervention to Enhance PrEP Adherence During Pregnancy and BreastfeedingRecruitingNCT04472884Not applicable
• UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 InfectionNot yet recruitingNCT04406727Phase 3
• Probiotic Supplementation for Those Immune Non-responders With HIV-1 InfectionRecruitingNCT04297488Not applicable
• Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1)AvailableNCT04233047
• Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.RecruitingNCT04160455
• Skeletal Muscle Energetics and Fatiguability in Older IndividualsRecruitingNCT04142047
• The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cARTRecruitingNCT03980665Phase 1
• Dolutegravir Plus Lamivudine Simplified TherapyRecruitingNCT03884673
• Imaging Immune Activation in HIV by PET-MRRecruitingNCT03684655Phase 2
• Simplified Treatment of Anti-retrovirus in China (C-STAR)RecruitingNCT03603977
• Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant WomenRecruitingNCT03564613
• GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIVAvailableNCT03462810
• The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune FunctionRecruitingNCT03240328Phase 1
• Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV InfectionRecruitingNCT03147859Phase 2
• Feasibility of an Ingestible Sensor System to Measure PrEP Adherence in YMSMNot yet recruitingNCT02891720Not applicable
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV RemissionRecruitingNCT02140255Phase 1/2
• the ANRS CO21 " Extreme " Cohort (CODEX)RecruitingNCT01520844Not applicable
• Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.RecruitingNCT00825929
• Antiretroviral Therapy for Acute and Chronic HIV InfectionRecruitingNCT00796263Phase 3
• Characterization of Acute and Recent HIV-1 Infections in Zurich.RecruitingNCT00537966
• A Long-term Follow-up of the HIV-NAT CohortRecruitingNCT00411983
• SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruitingNCT00187512
• Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research ParticipantsRecruitingNCT00039689
• Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressorsRecruitingNCT00029445
• Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare SettingCompletedNCT07498153Not applicableResults posted
• Male Partner Engagement in HIV Testing Using Partner-notification Slip Plus Oral HIV Self-testing KitCompletedNCT07488221Not applicableResults posted
• Multi-component Intervention to Train Providers to Promote PrEP for Girls and Women in the Deep SouthCompletedNCT06487390Not applicableResults posted
• HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital SettingCompletedNCT06282328Results posted
• Project Phakama: Testing Support Strategies to Empower Young Women on PrEP in South AfricaCompletedNCT06274060Not applicableResults posted
• VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1CompletedNCT06214052Phase 2Results posted
• Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, WashingtonCompletedNCT06187064Not applicableResults posted
• HIV Engagement and Adolescent Depression Support (HEADS-UP)CompletedNCT06173544Not applicableResults posted
• Testing a Barbershop-based HIV Prevention Initiative Among MenCompletedNCT06148584Not applicableResults posted
• Analysis of Cellular Kinases and Aging in PBMCs and Colorectal TissueCompletedNCT06132386Results posted
• A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1TerminatedNCT06061081Phase 2Results posted
• Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected AdultsCompletedNCT06039579Phase 2Results posted
• Heart Failure Polypill at a Safety Net HospitalCompletedNCT06029712Phase 2Results posted
• Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American CountriesActive, not recruitingNCT06002126Not applicableResults posted
• Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIVCompletedNCT05965427Results posted
• Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS Pilot)CompletedNCT05938413Not applicableResults posted
• Impact of a Telenovela/Soap Opera for HIV Prevention in LatinasCompletedNCT05929482Not applicableResults posted
• Planning a Multi-Level Intervention to Reduce Substance Use Stigma in HIV Prevention and CareCompletedNCT05925374Not applicableResults posted
• A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAFCompletedNCT05911360Phase 3Results posted
• Start the Conversation: Evaluating Implementation of a Multi-level PrEP Initiative for Black Cisgender Women in NolaCompletedNCT05909176Not applicableResults posted
• Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR StudyCompletedNCT05896748Phase 3Results posted
• Enhanced Virologic Monitoring for Pregnant and Postpartum Women With HIVCompletedNCT05845619Not applicableResults posted
• Implementation a Data-to-Care Strategy to Improve HIV Continuum Outcomes for Out of Care People Living With HIV (PLWH) in UkraineCompletedNCT05821413Not applicableResults posted
• Youth Ending the HIV EpidemicCompletedNCT05789875Not applicableResults posted
• Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIVCompletedNCT05781542Phase 1Results posted
• Skills to Empower Affirmative MenCompletedNCT05732675Not applicableResults posted
• An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP StrategyCompletedNCT05709860Not applicableResults posted
• ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised IndividualsTerminatedNCT05655546Not applicableResults posted
• Development and Pilot Testing of the Sense2Quit AppCompletedNCT05609032Not applicableResults posted
• Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in BrazilCompletedNCT05560243Not applicableResults posted
• Pain Inflammation and Cannabis in HIVCompletedNCT05554146Not applicableResults posted
• A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE TerritoriesCompletedNCT05514509Phase 4Results posted
• Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCCompletedNCT05510908Results posted
• MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004)CompletedNCT05494736Phase 1Results posted
• Testing Implementation Strategies to Improve Delivery of PrEP for Pregnant and Postpartum Women in KenyaCompletedNCT05482360Not applicableResults posted
• SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject DrugsCompletedNCT05480956Not applicableResults posted
• Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus LevelsTerminatedNCT05458102Phase 1Results posted
• Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDSCompletedNCT05454514Not applicableResults posted
• Le Kip Kip: A Campaign to Change Social Norms and Build Sustainable Demand for PrEP Among Women in South AfricaCompletedNCT05417620Not applicableResults posted
• Simplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach Among Excluded Population. (SIMPLIFIED)CompletedNCT05405751Phase 4Results posted
• First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4011499 in Healthy ParticipantsCompletedNCT05393271Phase 1Results posted
• A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United StatesCompletedNCT05374525Phase 4Results posted
• AmbassADDOrs for Health StudyTerminatedNCT05357144Not applicableResults posted
• Package of Resources for Assisted Contact Tracing: Implementation, Costs, and EffectivenessCompletedNCT05343390Not applicableResults posted
• Technology-based Training Tool for PHAT LifeCompletedNCT05339412Not applicableResults posted
• HIV And Parasitic Infection (HAPI) StudyCompletedNCT05323396Not applicableResults posted
• A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult ParticipantsCompletedNCT05291520Phase 1Results posted
• A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral TherapyCompletedNCT05261191Phase 1Results posted
• The LEARN Study for CVD PreventionCompletedNCT05242952Not applicableResults posted
• A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult ParticipantsActive, not recruitingNCT05217641Phase 1Results posted
• A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult ParticipantsCompletedNCT05184452Phase 1Results posted
• Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult.CompletedNCT05182125Phase 1Results posted
• Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of ConcernCompletedNCT05168813Phase 2/3Results posted
• First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4004280 in Healthy ParticipantsCompletedNCT05163522Phase 1Results posted
• A Peer-Driven Intervention to Increase PrEP Uptake Among Minority MSMCompletedNCT05161663Not applicableResults posted
• The Women TAF-FTC Benchmark StudyCompletedNCT05140954Phase 2/3Results posted
• Mobilizing Social Network Resources for HIV Care SupportCompletedNCT05123274Not applicableResults posted
• Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)CompletedNCT05099965Phase 2Results posted
• Traditional Healer-initiated HIV Counseling and Testing in South AfricaCompletedNCT05079347Not applicableResults posted
• Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and TuberculosisCompletedNCT05065905Phase 1/2Results posted

← HIV Infections overview